(Total Views: 481)
Posted On: 02/15/2021 11:08:13 AM
Post# of 151715
Do we think we will be selling billions of dollars worth of Leronlimab for COVID in 2051?
A 30x multiple would require it. And, while we expect to have many more indications approved by then, a 30x multiple isn't reasonable until we have said approvals.
A 30x multiple would require it. And, while we expect to have many more indications approved by then, a 30x multiple isn't reasonable until we have said approvals.
(0)
(0)Scroll down for more posts ▼
